Honasa Consumer Limited (NSE:HONASA)
India
· Delayed Price · Currency is INR | Market Cap | 112.74B |
| Revenue (ttm) | 22.68B |
| Net Income (ttm) | 1.56B |
| Shares Out | 325.37M |
| EPS (ttm) | 4.78 |
| PE Ratio | 72.54 |
| Forward PE | 53.36 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 324,531 |
| Average Volume | 1,291,864 |
| Open | 347.40 |
| Previous Close | 346.50 |
| Day's Range | 345.40 - 351.85 |
| 52-Week Range | 230.10 - 359.75 |
| Beta | 0.33 |
| RSI | 67.80 |
| Earnings Date | May 22, 2026 |
About Honasa Consumer
Honasa Consumer Limited operates as a digital beauty and personal care company in India and internationally. The company provides body and baby care, skin and hair care, color cosmetics, other related personal care under Mamaearth, The Derma Co., Aqualogica, Ayuga, Staze and Dr. Sheth’s brands. It offers beauty salon and hair styling services under the BBlunt brand; and operates Momspresso, a content development and influencer marketing platform. The company was formerly known as Honasa Consumer Private Limited and changed its name to Honasa Co... [Read more]
Financial Performance
In fiscal year 2025, Honasa Consumer's revenue was 20.67 billion, an increase of 7.66% compared to the previous year's 19.20 billion. Earnings were 726.87 million, a decrease of -35.00%.
Financial StatementsNews
Honasa Consumer Transcript: Q3 25/26
Achieved record revenue and profitability with 21.7% YoY growth, driven by strong core and young brand performance, margin expansion, and successful channel execution. Confident in sustaining growth and margin improvement, with focus on premiumization, innovation, and strategic acquisitions.
Honasa Consumer Transcript: Q2 25/26
Q2 FY26 saw 22.5% revenue growth, record gross margins, and strong performance from core and young brands. Mamaearth and The Derma Co led growth, while new launches and investments in prestige and oral care signal a focus on premiumization and innovation.
Honasa Consumer Transcript: Q1 25/26
Highest ever quarterly revenue and PAT achieved, with 7.5% YOY growth and strong volume-led performance. Focus categories and young brands drove double-digit growth, while margin expansion and cash generation remain priorities. Double-digit growth and 7% EBITDA margin are guided for the rest of FY26.
Honasa Consumer Transcript: Q4 24/25
Q4 saw 13.3% revenue growth and strong cash generation, with focus categories in Mamaearth returning to double-digit growth in key channels. Young brands grew 30%+, and Derma Co achieved INR 100 crore ARR offline. FY 2026 targets double-digit growth and improved EBITDA margins.
Honasa Consumer Transcript: Q3 24/25
Non-Mamaearth brands grew over 30% YTD, now making up 40%+ of revenue, while Mamaearth declined, especially in General Trade. Distribution overhaul is complete in top 50 cities, with quick commerce now 7-8% of sales. Margin recovery and growth are expected in FY26 H2.
Honasa Consumer Transcript: Q2 24/25
Q2 was marked by a significant inventory correction and sales return, leading to a negative EBITDA margin. Management is overhauling distribution and focusing investments on core categories, expecting a gradual recovery over the next few quarters.
Honasa Consumer Transcript: Q1 24/25
Q1 FY25 saw 19.3% YoY growth, record profitability, and strong gross margin at 71.7%. Project Neev's inventory correction will impact one quarter, but full-year guidance of 20%+ growth and 150 bps margin expansion is maintained. Quick commerce and innovation continue to drive growth.